Cytokinetics inc
WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates … WebApr 10, 2024 · SOUTH SAN FRANCISCO, Apr 10, 2024 (GLOBE NEWSWIRE via COMTEX) -- SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- …
Cytokinetics inc
Did you know?
WebHeadquarters United States of America. Address ., 280 East Grand Avenue, South San Francisco, California, 94080. Website cytokinetics.com. Telephone 1 650 6243000. No of Employees 253. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange CYTK (NASD) Revenue (2024) $70.4M 26.2% (2024 vs 2024) EPS XXX. WebAbout The Company. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing potential treatments for debilitating diseases in which muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug ...
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled ...
WebDec 9, 2024 · Cytokinetics continues its over 20-year history of pioneering innovation in muscle biology and related pharmacology focused to diseases of muscle dysfunction and conditions of muscle weakness. WebCytokinetics Inc. is discontinuing its late-stage study of a drug aimed at amyotrophic lateral sclerosis, the potentially deadly neuromuscular condition commonly known as Lou Gehrig's Disease.
WebFeb 2, 2024 · Cytokinetics is preparing for the potential commercialization of tirasemtiv in North America and Europe and has granted an option to Astellas Pharma Inc. for development and commercialization in other countries. Cytokinetics is collaborating with Astellas to develop CK-2127107, a next-generation fast skeletal muscle activator.
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. signature sewing machine tension regulatorWebCytokinetics. Pharmaceuticals · California, United States · 253 Employees . Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. the promise within temptationWebMar 27, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people … Cytokinetics is a late-stage biopharmaceutical company focused on … Cytokinetics, Inc. does not by its reference above or distribution imply its … Cytokinetics is dedicated to helping underserved patient populations which … SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of … The key to muscle function is contraction. The principal functionality of muscle is … Heart failure affects 64 million people worldwide, hospitalizes more Americans … signatures for all in javaWebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate signatures for business emailsWebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% … the promise turkish castWebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with ... the promise yanna crawleyWebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential … signatures for work emails